DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Pluristem Therapeutics, Inc. (PSTI)
« Back to company indexPSTI Chatter Timeline
Stock Ticker for PSTI
Most Active Tweeters for PSTI
| User | Tweets |
|---|---|
| @bulletin_en | 7 |
| @thefinreviewer | 6 |
| @BlogYomi | 4 |
| @GantosJ | 4 |
| @TranscriptDaily | 2 |
Recent Tweets for PSTI
 |
@stocknewstimes Analysts Set Pluristem Therapeutics Inc. $PSTI Target Price at $3.83 https://t.co/yyEGHGy9hQ March 21st 2019, 5:03pm |
 |
@UlmHi AgeX Therapeutics Inc. $PSTI https://t.co/ZiFJY6wp3u March 20th 2019, 8:03pm |
 |
@BlogYomi Vascular Biogenics Ltd. $PSTI Contrasting side by side https://t.co/qyOgZrMRP7 March 20th 2019, 12:03pm |
 |
@bulletin_en Pluristem Therapeutics Inc $PSTI Sellers Declined Their Shorts By 1.24% As Of Mar 19, 2019 https://t.co/aJMeINfh70 March 19th 2019, 5:03pm |
 |
@macondailynews Brokerages Set Pluristem Therapeutics Inc. $PSTI Price Target at $3.83 https://t.co/gbhIwIL0Tt March 19th 2019, 1:03pm |
 |
@TheMarketsDaily Pluristem Therapeutics Inc. $PSTI Given Average Recommendation of “Buy” by Analysts https://t.co/hySs869Uvk March 19th 2019, 1:03pm |
 |
@shmulic12 $PSTI - weekly bearish with SHS - #PSTI chart https://t.co/jF6FwAnBB8 March 19th 2019, 10:03am |
 |
@thefinreviewer Reviewing Eidos Therapeutics Inc. $PSTI's results https://t.co/Zdb5e6RWKJ March 19th 2019, 2:03am |
|
@BlogYomi Comparison of Zai Lab Limited $PSTI https://t.co/u4QOJNaK0a March 18th 2019, 11:03pm |
 |
@Stock_News_Now $PSTI: New SEC Filing for PSTI: Form 8-K (No. 0001178913-19-000855): https://t.co/81RD9qA4cR March 18th 2019, 4:03pm |
 |
@StockTexts $PSTI Pluristem Therapeutics, Inc. SEC Filing: Form 3 https://t.co/rvKVIGfOlb March 18th 2019, 4:03pm |
|
@macondailynews Reviewing Adaptimmune Therapeutics $ADAP and Pluristem Therapeutics $PSTI https://t.co/I8ahz2B2aW March 18th 2019, 1:03pm |
 |
@mmahotstuff1 Per Se Technologies Inc $PSTI Stock Sentiment Worsens https://t.co/IETLXopTEU March 18th 2019, 10:03am |
|
@mmahotstuff1 Pluristem Therapeutics Inc $PSTI Could Improve Your Long Portfolio After Less Shorts Reported https://t.co/MVvEd117nb March 18th 2019, 7:03am |
 |
@whatsonthorold2 Could Pluristem Therapeutics Inc $PSTI See a Reversal After Less Sellers Came In? https://t.co/1KpCWASfDX March 18th 2019, 7:03am |
 |
@bibeypost_stock It Seems Pluristem Therapeutics Inc $PSTI Will Go Up. Just Reported Less Shorted Shares https://t.co/pD7K1UHZne March 18th 2019, 7:03am |
 |
@reurope_stock How Analysts Feel About Pluristem Therapeutics Inc $PSTI After Decrease in Sellers? https://t.co/I5GXyrbw4W March 18th 2019, 7:03am |
|
@BlogYomi Comparing of Kindred Biosciences Inc. $PSTI https://t.co/8sYuqjMtDL March 18th 2019, 6:03am |
|
@UlmHi Bath Savings Trust Co Has Lifted Its Brown Forman B $BF.B Stake; Pluristem Therapeutics $PSTI Has 0.82 Sentiment https://t.co/GpXjjC4jkn March 18th 2019, 6:03am |
|
@thefinreviewer BidaskScore Gives Pluristem Therapeutics $PSTI Higher Rating; Morgan Stanley India Investment Fund $IIF's Sentiment… https://t.co/eXCgB4lwoJ March 17th 2019, 1:03pm |
 |
@TranscriptDaily Pluristem Therapeutics Inc. $PSTI Receives $3.83 Average Price Target from Brokerages https://t.co/xW795Bm29Y March 17th 2019, 5:03am |
|
@thefinreviewer Reviewing Alder BioPharmaceuticals Inc. $PSTI's results https://t.co/clQigBCYz7 March 16th 2019, 11:03pm |
|
@thefinreviewer Reviewing Caladrius Biosciences Inc. $PSTI's results https://t.co/98X3kFvzOB March 16th 2019, 6:03pm |
|
@BlogYomi Comparing of Onconova Therapeutics Inc. $PSTI https://t.co/a6mMu6KKFv March 16th 2019, 3:03am |
 |
@dakotafinancial Pluristem Therapeutics Inc. $PSTI Given Consensus Rating of “Buy” by Analysts https://t.co/Fd5vmLminy March 14th 2019, 4:03am |
 |
@AmericanBanking Pluristem Therapeutics Inc. $PSTI Receives Average Rating of “Buy” from Brokerages https://t.co/wQcWHDA1wt #stocks March 14th 2019, 4:03am |
|
@thefinreviewer Reviewing Nabriva Therapeutics plc $PSTI's results https://t.co/t9c4gCbUCC March 13th 2019, 7:03am |
 |
@FinZTribune Big Money Are Selling Pluristem Therapeutics Inc $PSTI, Sentiment at 0.82 https://t.co/21q9KnNTTb March 13th 2019, 7:03am |
|
@bulletin_en Big Money Are Selling Pluristem Therapeutics Inc $PSTI, Sentiment at 0.82 https://t.co/71cvsYC8yQ March 13th 2019, 7:03am |
|
@FinZTribune Per Se Technologies Inc $PSTI Stock Sentiment Falls to 0.82 https://t.co/DT5XES8FG0 March 13th 2019, 7:03am |
|
@bulletin_en Per Se Technologies Inc $PSTI Big Money Quarterly Sentiment at 0.82 https://t.co/Aq6NghRB71 March 13th 2019, 7:03am |
 |
@LifeSciAdvisors Pluristem Therapeutics $PSTI Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I… https://t.co/zZzGe9p3XK March 12th 2019, 5:03pm |
 |
@StockNewsNow $PSTI Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I… https://t.co/0ZFr1RdeIT March 12th 2019, 11:03am |
 |
@StunningFeline RT @GantosJ: It's a +ve news for $PSTI as the DSMB approve moving to the highest dose in incomplete Hematopoietic recovery following HCT-He… March 12th 2019, 10:03am |
 |
@GantosJ It's a +ve news for $PSTI as the DSMB approve moving to the highest dose in incomplete Hematopoietic recovery follo… https://t.co/YEvi7iGJqp March 12th 2019, 10:03am |
 |
@JustTradingHoy $PSTI jumped in Jan 17 to 1.90 on this same study news to pull back down to 1.60s? What's different just an extra 8 weeks? March 12th 2019, 8:03am |
|
@biostockinfo RT @BioStocks: $PSTI Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18 March 12th 2019, 8:03am |
|
@GantosJ $PSTI The third and final cohort will be comprised of 15 patients that will receive two administrations of four mil… https://t.co/KRdDMTWls9 March 12th 2019, 8:03am |
|
@GantosJ $PSTI Results from the first two cohorts demonstrate PLX-R18 is safe and well tolerated, with early signals of effi… https://t.co/rhS3MGDo6B March 12th 2019, 8:03am |
|
@GantosJ $PSTI Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I… https://t.co/z40nJauTbO March 12th 2019, 8:03am |
 |
@bthefirsttoknow $PSTI Pluristem Therapeutics Announces Completion of .... https://t.co/lWlxoioYr0 March 12th 2019, 8:03am |
 |
@BioStocks $PSTI Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18 March 12th 2019, 8:03am |
|
@whatsonthorold2 Pluristem Therapeutics Inc $PSTI's Stock Is Buy After Less Market Selling https://t.co/76vtreviMw March 11th 2019, 8:03am |
|
@bulletin_en Pluristem Therapeutics Inc $PSTI Shorts Reduced By 1.24% As Of Mar 11, 2019 https://t.co/2WxYEyglcF March 11th 2019, 8:03am |
|
@TranscriptDaily Pluristem Therapeutics $PSTI and Adaptimmune Therapeutics $ADAP Critical Review https://t.co/ieSSC58r4B March 11th 2019, 4:03am |
|
@AmericanBanking Pluristem Therapeutics $PSTI and Adaptimmune Therapeutics $ADAP Critical Review https://t.co/ZSv0ac1y75 #stocks March 11th 2019, 4:03am |
|
@thefinreviewer Reviewing Magenta Therapeutics Inc. $PSTI's results https://t.co/viuV6jvecS March 11th 2019, 12:03am |
 |
@BiotechBlues At The Drop Of A Hat_Pluristem Therapeutics $PSTI CEO TO Detail Huge Partnership Agreement With Leading US Company… https://t.co/iArKlaCUs2 March 10th 2019, 11:03pm |
|
@bibeypost_stock Pluristem Therapeutics Inc $PSTI Stock Sentiment Worsens https://t.co/KZrbvo7f62 March 10th 2019, 8:03am |
|
@bulletin_en Cyclacel Pharmaceuticals Inc. $PSTI Contrasting side by side https://t.co/AzbqErfnUk March 9th 2019, 9:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.